Miha Butinar
Professor
Biochemistry and Molecular Biology
Jozef Stefan Institute
Slovenia
Biography
Dr. Miha Butinar completed phD in 2009 from Jočef Stefan International Postgraduate school
Research Interest
Biochemistry, molecular genetics, cell biology, physiology, pathophysiology and working as young researcher at Jočef Stefan Institute
Publications
-
Mirković B, Markelc B, Butinar M, Mitrović A, Sosič I, Gobec S, Vasiljeva O, Turk B, Čemažar M, Serša G, Kos J. Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity. Oncotarget. 2015 Aug 7;6(22):19027.
-
Maher K, Kokelj BJ, Butinar M, Mikhaylov G, Manček-Keber M, Stoka V, Vasiljeva O, Turk B, Grigoryev SA, Kopitar-Jerala N. A role for stefin B (cystatin B) in inflammation and endotoxemia. Journal of Biological Chemistry. 2014 Nov 14;289(46):31736-50.
-
Butinar M, Prebanda MT, Rajkovic J, Jeric B, Stoka V, Peters C, Reinheckel T, Krüger A, Turk V, Turk B, Vasiljeva O. Stefin B deficiency reduces tumor growth via sensitization of tumor cells to oxidative stress in a breast cancer model. Oncogene. 2014 Jun 26;33(26):3392.
-
Kljun J, Bratsos I, Alessio E, Psomas G, Repnik U, Butinar M, Turk B, Turel I. New uses for old drugs: attempts to convert quinolone antibacterials into potential anticancer agents containing ruthenium. Inorganic chemistry. 2013 Jul 25;52(15):9039-52.
